Regulations.gov document
Guidance for Industry on Regulatory Considerations for Human Cell, Tissues, and Cellular…
Other · FDA-2017-D-6146 · posted Nov 17, 2017
Key facts
| Document ID | FDA-2017-D-6146-0002 |
|---|---|
| Title | Guidance for Industry on Regulatory Considerations for Human Cell, Tissues, and Cellular and Tissue-Based Products Minimal Manipulation and Homologous Use |
| Document type | Other |
| Agency | FDA |
| Docket | FDA-2017-D-6146 |
| Posted | Nov 17, 2017 |
At a glance
- 1–9 Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: